Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Todd Huzar

Surgical Critical Care Houston, TX Medical Doctor

NPI 1427226661 CMS profile 155147

6411 Fannin St, Houston, TX 77030

Open in the dashboard

General payments

$8,608

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Todd Huzar of Houston, TX is reported in the CMS Open Payments database as having received $8,608 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $646 18
2024 General $1,439 13
2023 General $1,320 13
2022 General $885 5
2021 General $329 7
2020 General $1,564 2
2019 General $2,426 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Todd Huzar
  • Surgical Critical Care median
  • Middle half of Surgical Critical Care
  • National median

In program year 2025, general payments to Todd Huzar were reported at $646. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.

Show as a table
Year Todd Huzar Surgical Critical Care median Middle half National median
2019 $2,426 $161 $57–$631 $163
2020 $1,564 $116 $33–$383 $114
2021 $329 $121 $37–$475 $132
2022 $885 $163 $53–$789 $149
2023 $1,320 $188 $67–$1,031 $160
2024 $1,439 $216 $80–$1,133 $164
2025 $646 $231 $82–$1,489 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $2,142 9 payments
  2. Mallinckrodt Enterprises LLC $1,875 2 payments
  3. Mallinckrodt Hospital Products Inc. $1,500 1 payment
  4. Avita Medical Americas, LLC $767 15 payments
  5. PolyMedics Innovations Inc $712 19 payments
  6. PolyNovo North America LLC $560 8 payments
  7. Integra LifeSciences Corporation $443 3 payments
  8. Smith+Nephew, Inc. $144 2 payments
  9. Argentum Medical $136 1 payment
  10. Acera Surgical, Inc. $119 1 payment
  11. Other $210 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,233 66 payments
  2. Consulting Fee $3,375 3 payments
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose Wound Care $2,094 6 payments
  2. Kerecis Omega3 Marigen Wound Care $1,415 5 payments
  3. Kerecis Omega3 GraftGuide $1,322 3 payments
  4. Kerecis Omega3 Marigen Wound Care $772 3 payments
  5. Kerecis Omega3 Marigen Wound Care $772 3 payments
  6. Kerecis Omega3 Marigen Wound Care $772 3 payments
  7. Kerecis Omega3 SurgiClose Wound Care $679 1 payment
  8. Kerecis Omega3 Marigen Wound Care $679 1 payment
  9. Kerecis Omega3 SurgiClose Wound Care $679 1 payment
  10. Kerecis Omega3 Marigen Wound Care $644 2 payments
  11. Other $5,053 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$20,369

Medicare's payments for the services billed

Medicare patients

18

Average age 66

Services billed

240

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Cancer 0%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record